PTHS PTHS Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number

Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number at other companies

Arcutis Biotherapeutics, Inc.ARQT

——

TTR

Turn Therapeutics Inc. Common StockTTRX

——

Other financials

Income statement

See full

Revenue$10.9M—

Gross profit$9.2M—

Operating income-$13.1M-614%

Net income-$10.2M-420%

EPS (diluted)-$3.09+3.7%

Balance sheet

See full

Cash & equivalents$32.0M+24,250%

Total debt$29.6M—

Total equity$35.1M+937%

Total assets$145.4M+15,855%

Cash flow

See full

Operating cash flow-$13.1M-1,977%

CapEx$194.0K—

Free cash flow-$13.3M-2,008%

Valuation

See full

Market cap$98.22M+75.4%

Enterprise value$95.89M—

P/S3.6×—

Profitability

See full

Gross margin79.6%—

Operating margin-157.7%—

Net margin-186.2%—

FCF margin-60.8%—

Returns & leverage

See full

Return on equity-333.8%—

Debt / equity0.8×—

Current ratio2.8×+2.6×

Where this comes from

Reported directly by PTHS in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber.

The official record: PTHS’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTHS's share based compensation arrangement by share based payment award options exercisable number.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is PTHS's share based compensation arrangement by share based payment award options exercisable number?: PTHS (PTHS) reported share based compensation arrangement by share based payment award options exercisable number of $187.36K in Q1 2026.
How has PTHS's share based compensation arrangement by share based payment award options exercisable number changed year-over-year?: PTHS's share based compensation arrangement by share based payment award options exercisable number increased by 340.6% year-over-year, from $42.52K to $187.36K.